Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3249557
Max Phase: Preclinical
Molecular Formula: C43H69N13O11
Molecular Weight: 944.10
Molecule Type: Protein
Associated Items:
ID: ALA3249557
Max Phase: Preclinical
Molecular Formula: C43H69N13O11
Molecular Weight: 944.10
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N(C)CC(=O)N[C@H](C(=O)O)[C@@H](C)OC
Standard InChI: InChI=1S/C43H69N13O11/c1-9-24(4)35(40(63)52-31(18-27-19-47-22-49-27)41(64)56(7)21-33(59)53-36(42(65)66)25(5)67-8)55-38(61)30(17-26-12-14-28(57)15-13-26)51-39(62)34(23(2)3)54-37(60)29(50-32(58)20-46-6)11-10-16-48-43(44)45/h12-15,19,22-25,29-31,34-36,46,57H,9-11,16-18,20-21H2,1-8H3,(H,47,49)(H,50,58)(H,51,62)(H,52,63)(H,53,59)(H,54,60)(H,55,61)(H,65,66)(H4,44,45,48)/t24-,25+,29-,30-,31-,34-,35-,36-/m0/s1
Standard InChI Key: LQWAUYXRFLMWIB-DZLNWWCLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 944.10 | Molecular Weight (Monoisotopic): 943.5240 | AlogP: -2.43 | #Rotatable Bonds: 29 |
Polar Surface Area: 364.28 | Molecular Species: ZWITTERION | HBA: 13 | HBD: 13 |
#RO5 Violations: 3 | HBA (Lipinski): 24 | HBD (Lipinski): 14 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.77 | CX Basic pKa: 11.43 | CX LogP: -4.79 | CX LogD: -5.73 |
Aromatic Rings: 2 | Heavy Atoms: 67 | QED Weighted: 0.02 | Np Likeness Score: -0.08 |
1. Moore GJ, Oudeman EM, Ko D, Nystrom DM.. (1979) Synthesis of angiotensin II antagonists containing sarcosine in position 7., 22 (9): [PMID:490564] [10.1021/jm00195a032] |
Source(1):